MSB 7.69% $1.19 mesoblast limited

Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-7

  1. wot
    9,859 Posts.
    lightbulb Created with Sketch. 1379
    Mesoblast is now working towards a pre-BLA meeting with the FDA. Commercial roll out now assured. Good luck shorters, you are going to need it.. Now we wait for partners to line up.. reckon we will tie something up in the coming days.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.